magazine archive
magazine archive
Week Ahead
Centrica’s switch watch and payout threat
Thursday 15 Feb 2018Having lost 823,000 UK consumer energy customers in the third quarter, all eyes are on Centrica ( CNA ) ahead of full year figures on 22 February. The owner of the UK’s biggest household energy supplier British Gas has had a difficult year, prompting a profit warning in November. That puts its...
Busy February for AVEVA
Thursday 08 Feb 2018Deadlines are coming thick and fast for industrial design software supplier AVEVA ( AVV ) . The group expects to get the sign-off from US regulators on 9 February for its proposed £3bn merger with the software arm of French engineer Schneider Electric. That will swiftly be followed on 15 February...
Galliford Try to address Carillion fallout
Thursday 08 Feb 2018Management will be looking to draw a clear line between their charge and liquidated construction services business Carillion ( CLLN ) when Galliford Try ( GFRD ) reports its half year results on 14 February. Since the news of Carillion’s collapse on 15 January, Galliford Try’s shares have lost 18%...
Why ConvaTec needs to clarify the extent of its supply crisis
Thursday 08 Feb 2018Supply issues and a fall in full year revenue growth toppled ConvaTec’s ( CTEC ) shares late last year, leaving the wound care specialist trading below the 225p price at which it joined the stock market in October 2016. Shares in ConvaTec are now trading at 188.65p. The company publishes its half...
Can Babcock turn it around?
Thursday 01 Feb 2018Shares in defence contract outsourcer Babcock ( BAB ) have been in decline for around three years. Weighing on the stock more recently have been Brexit concerns and a reduction in the Ministry of Defence’s spending. The company’s trading statement in September last year buoyed investors and...
Get ready for the FTSE 100 pharma reporting season
Thursday 01 Feb 2018We’re about to enter results season for the FTSE 100 drug developers. Full year results are expected from AstraZeneca ( AZN ) on 2 February and from peer GlaxoSmithKline ( GSK ) on 7 February. Shares in AstraZeneca have been gaining momentum since the second half of 2017 as the company’s prospects...
Yu set to deliver
Thursday 25 Jan 2018Investors eagerly await a full year trading update from Yu Group ( YU.:AIM ) on 29 January. The business energy supplier has released a string of upbeat announcements since making it on to Shares’ Great Ideas list in April 2017, when the stock was trading at 287.5p. Today the shares change hands...
Euromoney’s paper problem
Thursday 25 Jan 2018Business-to-business publisher Euromoney Institutional Investor ( ERM ) is set to update on trading on 1 February. With performance figures likely to feature in its 49%-owner Daily Mail & General Trust’s ( DMGT ) first quarter update on 25 January, investors’ focus may fall instead on Euromoney...
Can Domino’s deliver more sales momentum?
Thursday 25 Jan 2018Will Domino’s Pizza ( DOM ) continue to bounce back with strong trading or return to sluggish UK growth when it issues a trading update on 30 January? In the 13 weeks to 24 September, the pizza delivery chain unveiled UK sales growth of 8.1%. Investors should pay attention to any special deals at...
Can EasyJet continue to succeed as others fail?
Thursday 18 Jan 2018When low-cost airline EasyJet ( EZJ ) reports first quarter results on 23 January, the biggest question on investors’ lips will be whether it is continuing to win business from struggling or defunct rivals. Last year, EasyJet said revenue per seat growth was expected to be positive by ‘low to mid-...